The transgenic construct contains a hemagluttinin (HA) tagged mutant mouse Sgk1 sequence under the control of the cardiac-specific Myh6 promoter. The CA mutation replaces a serine at residue 436 (published as 422) for an aspartic acid (S436D), rendering the kinase constitutively active (CA). (J:210069)